603 filings
Page 6 of 31
8-K
stczy
10 Aug 20
Protalix BioTherapeutics Reports Second Quarter 2020
6:56am
S-8
ff7f2pvcq7v5eeoph7p
11 Jun 20
Registration of securities for employees
5:01pm
8-K
oal8wy
8 Jun 20
Protalix BioTherapeutics Appoints Yael Hayon, Ph.D. as its New Vice President, Research and Development
5:04pm
8-K
ne03j 87k
1 Jun 20
Protalix BioTherapeutics Reports First Quarter 2020
6:54am
8-K
x7kecagqns h05
28 May 20
Other Events
6:57am
8-K
gu52cv 9wjzsp3i4
11 May 20
Other Events
6:58am
8-K
b3kf0c
11 May 20
Other Events
6:06am
EFFECT
08vsu9m2 13j
30 Apr 20
Notice of effectiveness
12:15am
424B3
10jcdf6p29v
29 Apr 20
Prospectus supplement
5:12pm
CORRESP
2boghty8nwx
27 Apr 20
Correspondence with SEC
12:00am
UPLOAD
5w3rc5ii5tjerqrcjc
22 Apr 20
Letter from SEC
12:00am
8-K
ehcklwfx
18 Mar 20
Protalix BioTherapeutics Announces Closing of $43.7 Million Private Placement
4:05pm
8-K
pp0m7f9qhyzvoy
12 Mar 20
Protalix BioTherapeutics Reports Fourth Quarter and Full Year 2019
8:16am
8-K
5nwep0em
12 Mar 20
Protalix BioTherapeutics Announces $43.7 Million in Financing to
8:04am
8-K
6aykkhri6t2nsg8 ztv
10 Feb 20
Regulation FD Disclosure
4:16pm